Management of IRIS

  • Authors: Irini Sereti, MD, MHS; Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • IRIS is categorized as paradoxical IRIS or unmasking IRIS by whether the pathogen involved in the reaction has been diagnosed at the time of ART initiation
  • Immune features of paradoxical IRIS include monocyte/macrophage activation and T-cell reconstitution[Grant 2012; Pean 2012; Barber 2010; Barber 2012; Andrade 2013]
  • Unmasking IRIS is characterized by cytokine production similar to that seen in patients with active opportunistic infections[Haddow 2009; Porter 2010]

Action required

Keywords: IRIS, Tuberculosis

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.